Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventriculo-arterial Coupling and Myocardial Work in Sepsis
NCT06853574Not yet recruiting
- Sponsor
- General Hospital Celje
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of norepinephrine in sepsis and septic shock (2 arms), sponsored by General Hospital Celje. Primary endpoints: Changes in ventriculo-arterial coupling at 24 hours and Changes in myocardial work at 24 hours. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT06853574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853574.